Generalized Anxiety Disorder or GAD, (otherwise known as Anxiety), is a common mental health condition that can cause intense, persistent thoughts and worries about everyday situations. Anxiety can have a significant impact on someone’s life.
Anxiety disorders, including Generalized Anxiety Disorder, affect around 6.8 million adults or 3.1% of the population in the United States.1 This GAD study is researching the effectiveness and safety of an investigational study drug for adults with General Anxiety Disorder. If you qualify and choose to participate you will be helping to advance the research in the treatment of Anxiety.
You may be eligible to participate if you:
- Are between the ages of 18-65 years old, inclusive
- Have symptoms of Generalized Anxiety Disorder (GAD), such as:
- Difficulty controlling feelings of worry
- Feeling restless, wound-up, or on edge
- Difficulty concentrating
- Fatigue
- Irritability
- Trouble falling asleep or staying asleep
- Headaches, muscle aches, stomach aches
* Qualified study participants will receive all study-related procedures at no cost and may be reimbursed for travel and study-related expenses.
Qualified study participants may be reimbursed for travel and study-related expenses.
Sign Up
What happens if I sign up? We will try to match you to a research study location in your area that is currently screening potential study participants with Generalized Anxiety Disorder or will notify you if one becomes available. The study team will then contact you to discuss if you may be qualified to participate.
If you think you would like to participate in this GAD study or would like more information, please enter your information below. We will determine if you may qualify and contact you about the study. Keep in mind that participation is entirely voluntary. If you qualify and decide to take part in a study, you may change your mind about participating at any time.
About Generalized Anxiety Disorder
Generalized Anxiety Disorder or GAD, (otherwise known as Anxiety), is a common mental health condition that can cause intense, persistent thoughts and worries about everyday situations. Anxiety can have a significant impact on someone’s life.
Anxiety disorders, like Generalized Anxiety Disorder, affect around 6.8 million adults or 3.1% of the population in the United States.1
For many people, anxiety involves repeated and frequent fear, worry, and spiraling thoughts that can lead to anxiety and panic attacks.
Although anxiety can affect everyone differently, common symptoms can include:
- Difficulty controlling feeling of worry
- Feeling restless, wound-up, or on edge
- Difficulty concentrating
- Fatigue
- Irritability
- Trouble falling asleep or staying asleep
- Headaches, muscle aches, stomach aches
This GAD study is researching the effectiveness and safety of an investigational study drug for adults with Generalized Anxiety Disorder. If you qualify and choose to participate you will be helping to advance the research in the treatment of Anxiety.
Frequently Asked Questions
What is a research study?
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational study drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are research studies important?
A research study is part of the process by which new and innovative medications, interventions and treatments are evaluated before they can be approved and brought to market, so people can live happier and healthier lives. Even over-the-counter medications, such as NSAIDs you may have used to counteract a headache, have gone through the clinical research study process before they were available at your local pharmacy.
What is the purpose of the GAD study?
This GAD study is being conducted to assess the safety and effectiveness of an investigational study drug for adults with Generalized Anxiety Disorder. If you qualify and choose to participate you will be helping to advance the research in the treatment of Anxiety.
The investigational study drug is an experimental drug. “Experimental” means that the investigational study drug is currently being tested and is not approved for sale in the United States by the Food and Drug Administration (FDA).
What will the GAD study involve?
Approximately 464 adult study subjects across the globe will take part in this study. If you agree to take part, and the study doctor determines that the study is right for you, it is expected that you will be in the study for about 12 weeks. The study will include about 8 study center visits.
Will I receive compensation?
Qualified study participants may be reimbursed for travel and study-related expenses. Please discuss this with the study team when they contact you.
Is there a cost to participate?
There is no cost to participate in this GAD study.
What else do I need to consider?
The research team will be able to explain more about what this GAD study will involve, and, if the study doctor determines that the study is right for you, it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study center?
We match you to a study center within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decide you no longer want your information stored, you can opt out and we will delete your details.
About the GAD Study
The GAD Study is researching the safety and effectiveness of an investigational study drug for adults with Generalized Anxiety Disorder (Anxiety). If you qualify and choose to participate you will be helping to advance the research in the treatment of Anxiety.
About 464 participants at study centers across the globe will participate in this study.
Qualified study participants will receive all study-related procedures at no cost and may be reimbursed for travel and study-related expenses.
Who can take part in the GAD Study?
You may be eligible to participate if you:
- Are between the ages of 18-65 years old, inclusive
- Have symptoms of General Anxiety Disorder, such as:
- Difficulty controlling feeling of worry
- Feeling restless, wound-up, or on edge
- Difficulty concentrating
- Fatigue
- Irritability
- Trouble falling asleep or staying asleep
- Headaches, muscle aches, stomach aches
